News
AstraZeneca rolls out at-home service for FluMist nasal flu vaccine
AstraZeneca (LSE: AZN) has launched FluMist Home, the first FDA-approved influenza vaccine program that allows self- or caregiver administration. FluMist (influenza vaccine live, intranasal) can now be delivered directly to households,
AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important milestone for easier access to vaccinations in 34 U.S. states. This initiative likely contributed to its stock price increase of 12% last quarter,
FLUMIST, AstraZeneca’s FDA-approved flu nasal vaccine, can now be ordered and used at home with zero needles or clinic hassle ...
If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback